These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14241)

  • 1. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.
    Aranda JV; Gorman W; Bergsteinsson H; Gunn T
    J Pediatr; 1977 Mar; 90(3):467-72. PubMed ID: 14241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Efficacy and Safety of Caffeine and Aminophylline for Apnea of Prematurity in Preterm (≤34 weeks) Neonates: A Randomized Controlled Trial.
    Shivakumar M; Jayashree P; Najih M; Lewis LES; Bhat Y R; Kamath A; Shashikala -
    Indian Pediatr; 2017 Apr; 54(4):279-283. PubMed ID: 28474588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study.
    Erenberg A; Leff RD; Haack DG; Mosdell KW; Hicks GM; Wynne BA
    Pharmacotherapy; 2000 Jun; 20(6):644-52. PubMed ID: 10853619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
    He T; Liao ZC; Ding Y; Wang MJ; Li W; Gan JM; Yue SJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):684-689. PubMed ID: 32669161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants.
    Tobias JD
    South Med J; 2000 Mar; 93(3):294-6. PubMed ID: 10728517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants.
    Murat I; Moriette G; Blin MC; Couchard M; Flouvat B; De Gamarra E; Relier JP; Dreyfus-Brisac C
    J Pediatr; 1981 Dec; 99(6):984-9. PubMed ID: 7310594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine citrate in the NICU.
    Flood E
    Neonatal Netw; 1989 Apr; 7(5):37-9. PubMed ID: 2704353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants.
    Romagnoli C; De Carolis MP; Muzii U; Zecca E; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A
    Ther Drug Monit; 1992 Feb; 14(1):14-9. PubMed ID: 1546385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apneic spells and transcutaneous PO2: treatment with caffeine, 19-year follow-up.
    Koppe JG; de Bruijne JI; de Boer P
    Birth Defects Orig Artic Ser; 1979; 15(4):437-45. PubMed ID: 575301
    [No Abstract]   [Full Text] [Related]  

  • 12. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.
    Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM
    BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants.
    Brouard C; Moriette G; Murat I; Flouvat B; Pajot N; Walti H; de Gamarra E; Relier JP
    Am J Dis Child; 1985 Jul; 139(7):698-700. PubMed ID: 4014092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental aspects of percutaneous caffeine absorption in premature infants.
    Amato M; Hüppi P; Isenschmid M; Schneider H
    Am J Perinatol; 1992; 9(5-6):431-4. PubMed ID: 1418150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of caffeine on the ventilatory response to hypercarbia in preterm infants.
    Rossor T; Bhat R; Ali K; Peacock J; Rafferty GF; Greenough A
    Pediatr Res; 2018 Jun; 83(6):1152-1157. PubMed ID: 29790869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylxanthines in apnea of prematurity.
    Aranda JV; Turmen T
    Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of caffeine citrate on neural breathing pattern in preterm infants.
    Parikka V; Beck J; Zhai Q; Leppäsalo J; Lehtonen L; Soukka H
    Early Hum Dev; 2015 Oct; 91(10):565-8. PubMed ID: 26217936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.